Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 3618
Embargo will expire:
26-Jun-2019 11:00 AM EDT
Released to reporters:
19-Jun-2019 8:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism

Article ID: 714497

Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism

Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine, the Murdoch Children’s Research Institute in Australia and seven other medical institutions report that an experimental drug called vosoritide, which interferes with certain proteins that block bone growth, allowed the average annual growth rate to increase in a study of 35 children and teenagers with achondroplasia, a form of dwarfism. The patients’ average boost in height to about 6 centimeters (2.4 inches) per year is close to growth rates among children of average stature, and the side effects of the drug were mostly mild, according to the researchers.

Released:
18-Jun-2019 10:00 AM EDT
Open in New Tab
Comment
Newswise: Out of Many Ovarian Precancerous Lesions, One Becomes Cancer

Article ID: 714396

Out of Many Ovarian Precancerous Lesions, One Becomes Cancer

Johns Hopkins Medicine

In a novel study of cancer genetics using fallopian tube tissue from 15 women, researchers at the Johns Hopkins Kimmel Cancer Center say they have found evidence that the most common and lethal type of ovarian cancer arises not from a uniform group of precancerous lesions, but from individual growths found in groups genetically unrelated to each other.

Released:
17-Jun-2019 9:00 AM EDT
Open in New Tab
Comment
Newswise: Study: One-Fifth Of U.S. Surgeons Still ‘Overusing’ Riskier Procedure to Create Kidney Dialysis Access

Article ID: 714317

Study: One-Fifth Of U.S. Surgeons Still ‘Overusing’ Riskier Procedure to Create Kidney Dialysis Access

Johns Hopkins Medicine

Long-term hemodialysis is a lifesaver for approximately half a million patients in the United States with kidney failure (also known as end-stage renal disease, or ESRD) who are either waiting on or unsuitable for a kidney transplant. But before the external machinery can take over the function of the kidneys — filtering and cleansing wastes from the blood — a minor surgical procedure is needed to create a stable, functional and reusable access to the circulatory system, usually through blood vessels in the arm.

Released:
13-Jun-2019 10:00 AM EDT
Open in New Tab
Comment
Newswise: Implanted Drug ‘Reservoir’ Safely Reduces Injections for People with Macular Degeneration

Article ID: 714310

Implanted Drug ‘Reservoir’ Safely Reduces Injections for People with Macular Degeneration

Johns Hopkins Medicine

In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.

Released:
13-Jun-2019 9:00 AM EDT
Open in New Tab
Comment
Newswise: ‘Five Star’ Hospitals Often Provide Fewer Services Than Other Hospitals, New Data Suggests

Article ID: 714298

‘Five Star’ Hospitals Often Provide Fewer Services Than Other Hospitals, New Data Suggests

Johns Hopkins Medicine

If you’re looking for a top-notch hospital with a wide range of services, narrowing your list to hospitals with a five-star patient experience rating might lead you astray. Many five-star hospitals offer fewer services than those without five stars, according to a new study by Johns Hopkins researchers published June 10 in JAMA Internal Medicine.

Released:
12-Jun-2019 1:30 PM EDT
Open in New Tab
Comment
Newswise: Education, Intelligence May Protect Cognition, but Don’t Prevent Alzheimer’s Disease

Article ID: 714186

Education, Intelligence May Protect Cognition, but Don’t Prevent Alzheimer’s Disease

Johns Hopkins Medicine

In a search for clues to what may delay or prevent Alzheimer’s disease, Johns Hopkins Medicine scientists report that smarter, more educated people aren’t protected from the disease, but do get a cognitive “head start” that may keep their minds functioning better temporarily.

Released:
11-Jun-2019 9:00 AM EDT
Open in New Tab
Comment
Newswise: How to Improve Care for Patients with Disabilities? We Need More Providers Like Them

Article ID: 714077

How to Improve Care for Patients with Disabilities? We Need More Providers Like Them

Johns Hopkins Medicine

It is common for patients to prefer seeking care from a clinician similar to them — such as of the same gender, ethnicity and culture — who can relate to their experiences and make treatment plans that work better for their lives. To meet these preferences from patients and improve quality of care, a diverse clinician workforce that matches the diversity in the general population is needed. However, when it comes to patients with disabilities, the chance of getting a clinician “like them” is extremely low, which may lead to patients’ reluctance to seek care or follow prescribed interventions and treatments. Meanwhile, without adequate scientists with disabilities bringing perspectives to patient-centered research, the ability to improve care for patients with disabilities is limited.

Released:
10-Jun-2019 8:00 AM EDT
Open in New Tab
Comment
Newswise: Newly Discovered Immune Cell Linked to Type 1 Diabetes

Article ID: 713334

Newly Discovered Immune Cell Linked to Type 1 Diabetes

Johns Hopkins Medicine

Johns Hopkins Medicine researchers say mysterious, previously unseen “X cell” may be cause of type 1 diabetes

Released:
30-May-2019 11:00 AM EDT
Open in New Tab
Comment
Newswise: Johns Hopkins Technology That Integrates Earlier Cancer Detection Into Routine Medical Care Receives Record Venture Investment

Article ID: 713612

Johns Hopkins Technology That Integrates Earlier Cancer Detection Into Routine Medical Care Receives Record Venture Investment

Johns Hopkins Medicine

A pioneering blood test developed by Johns Hopkins researchers that incorporates earlier cancer detection into routine medical care will be developed by a new company that has raised the largest outside investment ever by a licensee of a Johns Hopkins technology.

Released:
30-May-2019 8:00 AM EDT
Open in New Tab
Comment

Showing results

110 of 3618

Chat now!